Veterinary Medicines

GALLIMUNE MG, injekcinė emulsija

Authorised
  • Mycoplasma gallisepticum, strain S6, Inactivated
Download as PDF

Product identification

Medicine name:
GALLIMUNE MG, injekcinė emulsija
Active substance:
  • Mycoplasma gallisepticum, strain S6, Inactivated
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma gallisepticum, strain S6, Inactivated
    1000000000.00
    Colony forming unit
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/99/1007/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/12/2022
Download

RV1007.pdf

Lithuanian (PDF)
Published on: 10/06/2022
Download